Guardant Health Stock Probability of Future Stock Price Finishing Over 29.39
| GH Stock | USD 31.04 0.00 0.00% |
Guardant |
Guardant Health Target Price Odds to finish over 29.39
The tendency of Guardant Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 29.39 in 90 days |
| 31.04 | 90 days | 29.39 | about 36.4 |
Based on a normal probability distribution, the odds of Guardant Health to stay above $ 29.39 in 90 days from now is about 36.4 (This Guardant Health probability density function shows the probability of Guardant Stock to fall within a particular range of prices over 90 days) . Probability of Guardant Health price to stay between $ 29.39 and its current price of $31.04 at the end of the 90-day period is about 9.76 .
Allowing for the 90-day total investment horizon the stock has the beta coefficient of 2.32 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Guardant Health will likely underperform. Additionally Guardant Health has an alpha of 0.3423, implying that it can generate a 0.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Guardant Health Price Density |
| Price |
Predictive Modules for Guardant Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Guardant Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Guardant Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Guardant Health is not an exception. The market had few large corrections towards the Guardant Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Guardant Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Guardant Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | 2.32 | |
σ | Overall volatility | 5.98 | |
Ir | Information ratio | 0.1 |
Guardant Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Guardant Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Guardant Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Guardant Health appears to be risky and price may revert if volatility continues | |
| The company generated the yearly revenue of 563.95 M. Annual Net Loss to common stockholders was (479.45 M) with gross profit of 293.21 M. | |
| Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35. | |
| Guardant Health has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Guardant Health Inc Partners with MiBA to Revolutionize Precision Oncology |
Guardant Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Guardant Stock often depends not only on the future outlook of the current and potential Guardant Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardant Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 112 M | |
| Cash And Short Term Investments | 1.2 B |
Guardant Health Technical Analysis
Guardant Health's future price can be derived by breaking down and analyzing its technical indicators over time. Guardant Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Guardant Health. In general, you should focus on analyzing Guardant Stock price patterns and their correlations with different microeconomic environments and drivers.
Guardant Health Predictive Forecast Models
Guardant Health's time-series forecasting models is one of many Guardant Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Guardant Health's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Guardant Health
Checking the ongoing alerts about Guardant Health for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Guardant Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Guardant Health appears to be risky and price may revert if volatility continues | |
| The company generated the yearly revenue of 563.95 M. Annual Net Loss to common stockholders was (479.45 M) with gross profit of 293.21 M. | |
| Guardant Health reports about 853.69 M in cash with (324.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35. | |
| Guardant Health has a poor financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Guardant Health Inc Partners with MiBA to Revolutionize Precision Oncology |
Check out Guardant Health Backtesting, Guardant Health Valuation, Guardant Health Correlation, Guardant Health Hype Analysis, Guardant Health Volatility, Guardant Health History as well as Guardant Health Performance. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.